willdate
ADVERTORIAL: DCB therapy offers a glimpse of interventional cardiology’s past and future
This advertorial is sponsored by Cardionovum
“Everything started with balloon inflations in t...
Home-based therapy can help to reduce anxiety and depression in cardiovascular patients
A randomised study led by Greater Manchester Mental Health NHS Foundation Trust (GMMH) and the U...
Cardiovascular News 68 – February 2023: US Edition
In this issue:
Medicare study reopens guideline debate around surgery and PCI in patients with ...
Cardiovascular News 68 – February 2023: OUS Edition
In this issue:
Medicare study reopens guideline debate around surgery and PCI in patients with ...
ADVERTORIAL: A step forward in scoring balloon catheter design
This advertorial is sponsored by iVascular
A new coronary scoring balloon dilatation catheter...
Automated alert tool “associated with a small decrease in contrast use” during PCI
Performance improvement company Biome Analytics has announced the publication of a study in Circulat...
TruLeaf Medical to trial “two-stage” TMVR platform
TruLeaf Medical is to conduct a first-in-human clinical trial of a “two-stage” transcatheter mit...
PCI can be performed as safely without on-site access to surgery, says SCAI
Percutaneous coronary intervention (PCI) without on-site surgical support is as safe as PCI at centr...
Cardiovascular-aortic community comes together at CX 2023
From cutting-edge aortic interventions to consensus on revascularisation strategies in the periphera...
ADVERTORIAL: A wealth of data underscore treatment choices for coronary DCBs
This advertorial is sponsored by B. Braun Melsungen AG
The modern field of percutaneous coron...
First patient treated in LeAAPS trial of left atrial appendage occlusion in cardiac surgery patients
AtriCure has announced that the first patient was treated in the LeAAPS clinical trial, a prospectiv...
Slow progress made on gender balance in cardiovascular trial leadership
Little progress has been made over the last decade in improving gender balance in leadership positio...
Nieves Gonzalo
Interventional cardiology is a rapidly evolving field, offering the opportunity to learn procedures ...
Medicare study reopens guideline debate around surgery and PCI in patients with multivessel coronary artery disease
An analysis of data from more than 100,000 patients with multivessel coronary artery disease und...
First US patient enrolled into study of Selution SLR coronary drug-eluting balloon
The first US patient has been enrolled at Medstar Washington Hospital Center (Washington DC, USA) in...
STS 2023: Risk assessment tool “sets a high bar” when considering alternatives to surgery in mitral valve repair
A new risk assessment tool has been produced to provide a comprehensive method for assessing ope...
Enrolment milestone reached in trial of angiography-based vessel fractional flow reserve in coronary revascularisation
Pie Medical Imaging has announced the enrolment of the 500th patient in the FAST III clinical trial,...
Trial of super saturated oxygen therapy after PCI begins enrolment
Zoll has announced that the first patient has been enrolled in the REAL SSO2 post-market observation...
Registry data point to a declining rate of complications among primary MR patients
The largest dedicated registry on mitral transcatheter edge-to-edge repair (M-TEER) in primary m...
Shockwave agrees to acquire Neovasc
Shockwave Medical has entered into a definitive agreement to acquire Neovasc Inc, developer of t...
US FDA approves use of Navitor TAVI valve in high-risk aortic stenosis patients
The US Food and Drug Administration (FDA) has approved the Navitor (Abbott) transcatheter aortic val...
Effects of short DAPT “consistent regardless of high bleeding risk and complex PCI”
Research evaluating the effects of high bleeding risk (HBR) and complex percutaneous coronary interv...
Pie Medical Imaging announces launch of CAAS Qardia 2.0 echocardiography software platform
Pie Medical Imaging has launched a new version of its echocardiography software platform—CAAS Qardia...
NICE lowers threshold for statins to prevent cardiovascular events
The UK’s National Institute for Health and Care Excellence (NICE) has published draft guidance recom...
HVR Cardio closes €10.7 million series B funding round
HVR Cardio has closed on a €10.7 million series B round of financing. The Series B Round was led...
Depression increases likelihood of non-adherence to medical therapy post-PCI
Patients with depression were 10–20% less likely to adhere to guideline-directed medical therapy aft...
Multidisciplinary teams at the heart of new guidelines on aortic disease management
Closer ties between cardiologists, cardiac surgeons and vascular surgeons will be a hallmark of the ...
MedAlliance’s Selution SLR receives coronary de novo IDE approval
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional US Food and Dr...
Preclinical study outlines key features of foam-based LAA closure device
A preclinical study demonstrating key features of the foam-based left atrial appendage closure d...
Cardiac Dimensions closes funding round to support US EMPOWER pivotal study
Cardiac Dimensions has closed a US$35 million Series D financing round. The financing was co-led...
Funding secured to advance development of Pulse IVL system
AVS has announced that it raised US$20 million in Series B financing, which the company says will ac...
Cardiovascular News’ top stories of 2022
Which stories, features and interviews captured the attention of the cardiovascular community across...
SCAI announces recipients of early career grant scheme
The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the four recipie...
No sex difference seen in outcomes for transcatheter tricuspid valve intervention
Transcatheter tricuspid valve intervention is associated with similar outcomes in both women and...
ReCor appoints Lara Barghout to lead commercialisation of Paradise renal denervation system
ReCor Medical and its parent company Otsuka Medical Devices have announced the appointment of La...
Enrolment begins in trial to assess new therapy in patients deemed unsuitable for anticoagulants
Anthos Therapeutics has announced that it has enrolled the first patient in LILAC-TIMI 76, a pha...
Johnson & Johnson completes Abiomed acquisition
Johnson & Johnson has today announced it has completed its acquisition of Abiomed. Abiomed is no...
Machine learning enables “clinically important” characterisation of coronary artery disease
Using machine learning and clinical data from electronic health records, researchers have constructe...
Stem cell plasters “could revolutionise treatment of congenital heart disease”
Researchers have developed ‘stem cell plasters’ which it is hoped will revolutionise the way sur...
Enrolment begins in Impella ECP pivotal trial after US FDA green light
The first two patients have been enrolled in the Impella ECP pivotal trial, after the US Food an...
STAR-T trial of antithrombotic removal system during cardiac surgery to continue
CytoSorbents Corporation has received the recommendation from the independent Data and Safety Mo...
First US procedure performed using ShortCut leaflet splitting device
Pi-Cardia has announced that the first patient in the USA has been successfully treated with ShortCu...
Cardiology societies urge rethink of randomised controlled trial design
The current model for randomised clinical trials must be redesigned for the modern age, according to...
Pilot study of wire pacing sleeve yields positive results in TAVI and PCI procedures
A first-in-human trial using a purpose-built device to provide direct wire pacing without the need f...
Corindus rebrands to Siemens Healthineers Endovascular Robotics
Corindus has been rebranded to Siemens Healthineers Endovascular Robotics and will sit as a dedi...
EU Commission to propose delay to MDR implementation
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the tran...
UK regulator approves dapagliflozin for use in heart failure across the full spectrum of left ventricular ejection fraction
AstraZeneca has today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) ...
TRICares secures financing to fund development of Topaz tricuspid valve replacement system
TRiCares has announce the second closing and completion of its Series C financing round, successfull...
First patient randomised in RESPONDER-HF trial of Corvia atrial shunt
Corvia Medical has announced that the first patient has been randomised in RESPONDER-HF, a globa...
ESC warns of cardiac device shortage due to implementation of MDR regulations in Europe
The European Society of Cardiology (ESC) has urged European Union (EU) health ministers to act to pr...
Postmarket data point to lower rates of PVL with Acurate neo2 TAVI valve
The addition of an annular sealing skirt, among other design changes in the Acurate neo2 transca...
TRISCEND trial reports one-year outcomes in patients undergoing transcatheter tricuspid valve implantation
One-year results from the TRISCEND study, investigating the Evoque (Edwards Lifesciences) tricus...
ADVERTORIAL: TAVI valve durability and reliability: How patient lifetime management is evolving
This advertorial is sponsored by Medtronic
Durability, reliability, accuracy. These are just ...
DurAVR heart valve system gets green light from US FDA for early feasibility study
Anteris Technologies has announced that the US Food and Drug Administration (FDA) has conditionally ...
First implant of MonarQ tricuspid valve replacement system performed in Copenhagen
inQB8 Medical Technologies, in partnership with Peijia Medical, has announced first successful i...
Nyra Medical secures investment for transcatheter mitral valve repair technology
Nyra Medical has announced the closing of a US$20 million Series A financing.
The round was c...
First-in-human procedure performed using Impella RP Flex
The first implant procedure using the Impella RP Flex (Abiomed) percutaneous pump, following its rec...
Late-breaking Xlimit randomised trial data shared at CSC 2022 congress
Data presented at an innovation session at the 2022 Structural and Coronary Intervention Course (CS...
Timothy D Henry
A pioneer of one of the first regional ST-segment elevation myocardial infarction (STEMI) systems in...
Carmat resumes commercial implants of Aeson artificial heart
Carmat has announced the resumption of commercial implants of its Aeson total artificial heart.
C...
CroíValve reports successful first in human implants of its Duo tricuspid coaptation valve system
CroíValve has announced the successful first in human implants of its Duo tricuspid coaptation v...
Cardiovascular News 67 – November 2022: OUS Edition
In this issue:
Latest evidence from key renal denervation trials
REVIVED-BCIS 2: PCI fails t...
Cardiovascular News 67 – November 2022: US Edition
In this issue:
Latest evidence from key renal denervation trials
REVIVED-BCIS 2: PCI fails t...
Rates of all-cause death align between invasive and conservative strategies in ISCHEMIA-EXTEND
Extended follow-up of the ISCHEMIA-EXTEND trial has shown no difference in rates of all-cause mo...
AI system to aid decision making for aortic aneurysm treatment
Viz.ai has announced a partnership with Illuminate, a developer of proprietary natural language proc...
Use of clinical support platform “reduces risk of kidney injury” from PCI
Patients at high risk for acute kidney injury (AKI), the most common complication of percutaneous co...
RELIEF clinical study to assess use of Cardioform septal occluder for migraine relief
WL Gore & Associates has announced that it is initiating the RELIEF clinical study—an invest...
Neovasc Reducer assigned outpatient reimbursement code from CMS
Neovasc has announced that the Centers for Medicare and Medicaid Services (CMS) has assigned the Neo...
New surgical thresholds and need for multidisciplinary teams reflected in revised aortic guidelines
The American College of Cardiology (ACC) and American Heart Association (AHA) have jointly published...
Johnson & Johnson reaches agreement to acquire Abiomed
Johnson & Johnson is to acquire Abiomed, it was announced today, after the two organisations ent...
Impella RP Flex with SmartAssist receives US FDA approval to treat right heart failure
Abiomed has announced that Impella RP Flex with SmartAssist has received US Food and Drug Administra...
Carmat gains approval to resume clinical study of total artificial heart
Carmat, developer of the Aeson total artificial heart, has announced that it has been granted th...
US FDA accepts post-approval study reports for Impella
Abiomed has announced the US Food and Drug Administration (FDA) has accepted and closed the post...
First patients treated in SAFE-TAVI clinical study
OpSens Medical has announced the successful completion of the first cases in a clinical study—SAFE-T...
Selution SLR receives US FDA investigational device exemption approval for coronary clinical trial
Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received US Food and Drug Administr...
Ticagrelor after CABG associated with a decreased risk of vein graft failure compared to aspirin
In patients undergoing coronary artery bypass graft (CABG) surgery, the addition of ticagrelor t...
LeAAPS trial to explore benefit of left atrial appendage occlusion in cardiac surgery patients at risk for stroke
Researchers are to investigate the safety and efficacy of performing left atrial appendage occlu...
AccurKardia and Mawi link up to add automated ECG analytics for the new Mawi Watch
AccurKardia, a software company that provides clinical-grade, device agnostic, automated electrocard...
HeartFlow receives US FDA approval for Plaque and RoadMap analysis AI products
HeartFlow has received US Food and Drug Administration (FDA) 510(k) clearance on two new, AI-pow...
MedAlliance to be acquired by Cordis
MedAlliance is to be acquired by Cordis, it was announced today, after the two companies reached agr...
Rates of stroke and embolism lower with apixaban compared to rivaroxaban
In a large, population-based study of patients with atrial fibrillation (AF) and valvular heart dise...
Abiomed gains FDA approval for Impella low profile sheath
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Abiomed to market a ne...
Swedish registry data point to survival benefit for younger patients undergoing CABG
An analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) has s...
Analysis shows survival benefit in high-risk PCI supported by Impella
An analysis of more than 2,000 patients from a large US real-world database finds that patients ...
Swedish and Dutch organisations agree to research collaboration
The Uppsala Clinical Research Center (UCR) and the European Cardiovascular Research Institute (E...
Minimally invasive aortic perfusion cannula receives EACTS Techno-College innovation award
The developers of a cannula for minimally-invasive central aortic perfusion—MIC-Cannula—received...
CathWorks gains Japanese regulatory approval for FFRangio system
CathWorks has announced approval of the fourth generation CathWorks FFRangio system by the Japan...
EACTS 2022: Global studies will fill gap for “high-quality evidence” on invasive treatment of ischaemic cardiomyopathy
A global research initiative will compare coronary artery bypass graft surgery (CABG) and percut...
EACTS 2022: “Wake up call” for trialists over gender balance
Clinical trials in cardiothoracic surgery must ensure that sufficient numbers of women are enrol...
Latest data underscore optimism for future of renal denervation
Ajay Kirtane (Columbia University Irving Medical Center New York-Presbyterian Hospital, New York...
Long-term P2Y12 monotherapy after PCI “may be a promising strategy”
Three-year outcomes from the SMART-CHOICE trial have shown that P2Y12 inhibitor monotherapy was asso...
Enrolment completed in trial comparing PCI in diabetic patients
ABILITY DIABETES-GLOBAL, a randomised controlled head-to-head trial comparing safety and efficacy of...
Puzzle Medical wins 2022 TCT Shark Tank innovation competition
Puzzle Medical Devices was announced as the winner of the Shark Tank innovation competition at the 2...
Rivaroxaban may be an option for reducing radial artery occlusion in transradial coronary procedures
The use of rivaroxaban for seven days after a transradial coronary procedure reduced the rate of...
Unloading with Impella for 30 minutes prior to PCI linked to reduced infarct size in STEMI patients
Results of a new per-protocol analysis of the ST-segment Elevation Myocardial Infarction Door-To...
First US TAVI procedure performed using SavvyWire guidewire
OpSens has announced that Philippe Genereux (Morristown Medical Center, Morristown, USA) has perform...
Data from BIOSOLVE-IV and BIOMAG-I trials shared at TCT 2022
Biotronik has announced the presentation of new full-cohort two-year BIOSOLVE-IV data. In a post...
FDA approves Onyx Frontier and Resolute Onyx stents for bifurcation PCI
Medtronic has received Food and Drug Administration (FDA) approval for the treatment of non-left mai...
Clinical trial of TAVI in severe aortic regurgitation completes enrolment
JenaValve Technology has announced the successful completion of patient enrolment in the ALIGN-AR Pi...
TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation
Analysis of data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) ...
TCT 2022: UNIVERSAL trial finds ultrasound did not reduce vascular complications during femoral access for cardiac procedures
Results from a multicentre randomised trial comparing ultrasound with fluoroscopic guidance vers...
Medtronic expands US rollout of Evolut FX TAVI system
Medtronic has announced the expanded US market release of its newest-generation, self-expanding tran...
Shockwave initiates all female coronary IVL registry study
Shockwave Medical has initiated a prospective coronary intervention study consisting of all female p...
Breakthrough device designation granted for SirPlux Duo coronary DCB in small vessels
Advanced NanoTherapies has been granted US Food and Drug Administration (FDA) breakthrough devic...
TCT 2022: Amulet occluder keeps pace with Watchman at three years
Long-term follow-up of patients with non-valvular atrial fibrillation (AF) receiving the Amplatz...
TCT 2022 hears “important data” from renal denervation trials
Findings from the RADIANCE II randomised pivotal trial, presented at the 2022 Transcatheter Card...
TCT 2022: Valentin Fuster receives career achievement award
The major contribution of Valentin Fuster (Mount Sinai Health System, New York, USA) to the fiel...
TCT 2022: Pascal non-inferior to MitraClip in head-to-head trial in degenerative MR patients
The first randomised trial to compare two transcatheter edge-to-edge repair (TEER) devices —CLAS...
TCT 2022: No difference in rates of post-TAVI stroke seen with cerebral embolic protection device in PROTECTED TAVR
Among patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) the use of...
US FDA grants 510(k) clearance for SavvyWire TAVI guidewire
OpSens has received 510(k) regulatory clearance from the US Food & Drug Administration (FDA) for...
Precision medicine and upstream interventions in focus at TCT 2022 curtain raiser
The 2022 Transcatheter Cardiovascular Therapeutics (TCT, 16–19 September, Boston, USA) opened wi...
Abiomed given green light for RECOVER IV randomised trial
Abiomed has announced two approvals from the US Food and Drug Administration (FDA) related to clinic...
Cardiac Implants announces successful adjustment procedure using its Tri-Ring device to treat TR
Cardiac Implants has announced the successful initial deployment of its annuloplasty ring with imple...
Enrolment completed in TRANSFORM 1 trial of MagicTouch DCB
Concept Medical has announced the successful completion of the TRANSFORM 1 RCT. The randomised c...
TAVI costs comparable to surgery in low-risk patients, Canadian researchers conclude
A budget impact analysis comparing transcatheter aortic valve implantation (TAVI) with surgical ...
Vascade vascular and venous closure devices gain CE mark
Haemonetics Corporation has received CE mark certification for its Vascade vascular closure and ...
Latest Sapien TAVI valve features anti-calcification technology
Edwards Lifesciences has announced the launch of the Sapien 3 Ultra Resilia valve—combining Edwards’...
Three-year data “reinforce safety and efficacy” of Abbott’s Amplatzer Piccolo in infants with PDA
Abbott has announced three-year data for its Amplatzer Piccolo occluder for the treatment of patent ...
The time for change is now: Call for action over “ageing and unbalanced” cardiothoracic surgery community
Analysis of the global make-up of the four largest global societies for cardiothoracic surgery sugge...
Results of cuffless blood pressure monitor presented at AHA Hypertension Sessions
Results of an analysis of Aktiia’s cuffless blood pressure (BP) monitoring system are being presente...
First patient joins study of SSO2 therapy post-PCI
Zoll Medical has announced that the first patient has been enrolled in the AMIHOT III post-approval ...
Abbott’s Amplatzer Talisman PFO occlusion system launched in Europe
Abbott has announced the European launch of its Amplatzer Talisman patent foramen ovale (PFO) occlus...
AtriAN initiates second trial of pulsed field ablation in cardiothoracic surgery patients with paroxysmal AF
AtriAN Medical has announced that it has completed enrolment of a second study using its selective p...
Tom Nguyen
As a proponent of minimally invasive cardiac surgery and transcatheter techniques, Tom Nguyen (Unive...
Cardiovascular News’ top 10 most popular stories of August 2022
The most read stories from across Cardiovascular News in August 2022 include highlights from the Eur...
FDA clears Viz.ai’s right-to-left ventricle ratio algorithm
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for an automated right ve...
Latest centre begins using Philips’ Verisight Pro 3D intracardiac echocardiography catheter
Royal Philips has announced that Baptist Health’s Miami Cardiac & Vascular Institute (Miami, USA...
New DAPT labelling approved for Watchman FLX device
Boston Scientific has received US Food and Drug Administration (FDA) approval to expand the inst...
First patient enrolled in Hyper II study evaluating hybrid approach in long diffuse CAD
Cardionovum has announced the enrolment of the first patient in the international Hyper II clini...
JenaValve raises US$100 Million to advance Trilogy TAVI system
JenaValve Technology has announced that it has completed the initial closing of a US$100 million Ser...
ESC 2022: Risk score predicts mortality for AF patients after TAVI
Researchers have developed a risk score to predict mortality for patients with atrial fibrillati...
ESC 2022: Survival benefit seen following use of Abbott’s HeartMate 3 LVAD
Abbott has announced the release of late-breaking showing that its HeartMate 3 heart pump extend...
ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures
Transradial access for percutaneous coronary procedures is associated with lower rates of all-ca...
ESC 2022: MASTER DAPT continues to show merit for shortened dual antiplatelet therapy out to 15 months post-PCI
Fifteen-month results from the MASTER DAPT trial have shown that the preserved ischaemic benefit...
ESC 2022: Kidney disease patients with coronary disease see no improvement in survival at five years with an invasive approach
In patients with advanced chronic kidney disease (CKD) and chronic coronary disease, an invasive...
ESC 2022: FRAME-AMI sheds light on best strategy for selecting non-infarct lesions for PCI
Selection of non-infarct related artery (IRA) lesions for intervention using fractional flow res...
ESC 2022: High-risk aortic stenosis could be picked up using AI
Late-breaking research presented at the European Society of Cardiology (ESC) annual congress (26...
ESC 2022: POST-PCI trial finds no benefit to routine functional testing in high-risk PCI patients
Among high-risk patients undergoing percutaneous coronary intervention (PCI), a follow-up strate...
ESC 2022: AI outshines sonographer echocardiogram assessment in EchoNet-RCT
Results of one of the first and only randomised, blinded trials to assess the use of an artifici...
ESC 2022: REVIVED data show PCI does not benefit patients with severe left ventricular dysfunction
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure ho...
ESC 2022: SECURE trial finds “polypill” results in lower risk of cardiovascular events compared to usual care
Use of a ‘polypill’ after myocardial infarction (MI)—an all-in-one pill containing an antiplatel...
ESC 2022: Timing of antihypertensive medication “makes no difference” to cardiovascular outcomes
The timing of dosing of antihypertensive medication—whether it is taken in the morning or in the...
Programme released for TCT MedTech Innovation Forum
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announced the programme...
Medtronic launches Onyx Frontier coronary stent following CE mark approval
Medtronic has announced the launch of its latest generation drug-eluting coronary stent—Onyx Frontie...
Cardiovascular News 66 – August 2022: OUS Edition
In this issue:
Call for action over age and gender profile of global cardiothoracic surgery com...
Cardiovascular News 66 – August 2022: US Edition
In this issue:
Call for action over age and gender profile of global cardiothoracic surgery com...
Miracor’s PiCSO technology approved by FDA for investigational device exemption study
Miracor Medical has announced the approval of an investigational device exemption (IDE) from the...
First-in-human procedure completed using ShortCut Mitral device
Pi-Cardia has announced a successful first-in-human treatment of the mitral valve with the ShortCut ...
Edwards gains CE mark for Pascal Precision system for mitral and tricuspid regurgitation
Edwards Lifesciences has announced that the company's Pascal Precision transcatheter valve repai...
Restore EF study “shows heart function, symptom improvements” for high-risk PCI patients supported by Impella
Abiomed has announced the results of the Restore EF study, demonstrating that Impella-supported hig...
CX Aortic Vienna: Cardiac and vascular surgeons collaborate at the vanguard of aortic care
CX Aortic Vienna returns in October for its third edition (24–26 October, Digital), bringing togethe...
AHA and CRF announce collaborative education programme
The American Heart Association (Association) and the Cardiovascular Research Foundation (CRF) have a...
Spotlight turns to TAVI in patients with moderate aortic stenosis
Ongoing clinical trials looking at transcatheter aortic valve implantation (TAVI) for patients w...
Cardiovascular News’ top 10 most popular stories of July 2022
The most read stories from across Cardiovascular News in July 2022 include reflections on the future...
“Worrisome” rise in cardiovascular disease predicted out to 2060
Projected rates of cardiovascular risk factors and disease will increase significantly in the USA by...
“Positive” 30-day outcomes for patients receiving Optimum transcatheter aortic valve
Thubrikar Aortic Valve has announced successful 30-day outcomes in the first two patients receiving ...
Cardiac surgeons among signatories to group seeking “critical appraisal” of evidence in cardiovascular medicine
Cardiac surgeons from North America, Europe and Latin America are among the signatories to a multidi...
Genetic “cure” for cardiomyopathy is selected as winner of Big Beat Challenge
A project to develop genetic therapies to effectively cure cardiomyopathy has been announced as ...
Three-year results of RANGO registry presented at EuroPCR
iVascular has announced the release of three-year observational data concerning its Angiolite cobalt...
Neovasc gains approval for protocol supplement to COSIRA-II trial
Neovasc has announced that the US Food and Drug Administration (FDA) has approved a protocol sup...
Digital drainage system for cardiac surgery “safe and effective”
Centese has announced the publication of the first peer-reviewed clinical study of its Thoraguard di...
Pi-Cardia gains FDA nod for study of ShortCut leaflet splitting device
Pi-Cardia has received Investigational Device Exemption (IDE) approval from the US Food and Drug Adm...
Ultrasound renal denervation meets primary efficacy endpoint in RADIANCE II study
ReCor Medical and Otsuka Medical Devices have announced that the RADIANCE II US Food and Drug Admini...
Steps needed to include disadvantaged patients in mitral and tricuspid trials
Incentives for the enrolment of patients from socieconomically disadvantaged groups, as well as ...
Cathbot completes enrolment in clinical study of robotic-assisted PCI in China
Cathbot—a joint venture between Robocath and MicroPort—has enrolled the last patient in its clinical...
Investigational device offers hope of a ‘shortcut’ to prevent coronary obstruction after TAVI
Preventing coronary obstruction after transcatheter aortic valve implantation (TAVI) becomes inc...
New funding for research to examine use of blood pressure cuffs for heart failure patients with pacemakers
A research project at the University of Leeds (Leeds, UK) aiming to find an easier way to establ...
FDA grants breakthrough status for Accucinch ventricular restoration system
Ancora Heart has announced that the US Food and Drug Administration (FDA) has granted Breakthrou...
First patients enrolled in study of Booster spiral balloon therapy for acute myocardial infarction
Intratech Medical has announced the successful enrolment of two patients in a multicentre first-in-h...
VenusP-Valve gains approval from China’s NMPA
The VenusP-Valve (Venus Medtech) transcatheter pulmonic valve replacement (TPVR) system has been...
Stress testing can guide patient selection for coronary revascularisation
Patients identified by nuclear stress testing as having severe stress-induced myocardial ischaem...
Echocardiographers face “under-recognised” radiation exposure risk in the cath lab
Echocardiographers may be at significantly greater risk of exposure to radiation than interventional...
TCT MedTech Innovation Forum to spotlight opportunities for innovation
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation have announced the launch of the...
Analysis shows “positive trend” with thinner strut stents in patients with small vessels
A subgroup analysis of the BIO-RESORT trial has shown a “trend towards better outcomes” with thi...
HeartBeam expands software platform to cover unstable angina
HeartBeam is expanding the available patient population for its emergency department software techno...
Cardiovascular News’ top 10 most popular news stories of June 2022
The most read stories from across Cardiovascular News in June 2022 include highlights from TVT 2022 ...
Female representation in interventional cardiology remains low, but there is cause for hope
Suzanne Baron and Ki Park detail some of the barriers facing women in the field of interventiona...
Advanced NanoTherapies closes Series A funding round
Advanced NanoTherapies has closed a US$7.2 million Series A equity financing round marking a tot...
EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients
Results from the first commercial implants of the Trilogy transcatheter aortic valve implantatio...
First patients enrolled in Manta Ultra vascular closure device study
Teleflex has announced the first patient enrolment in a clinical study that is intended to demon...
AF after surgery is linked to an increased risk of heart failure hospitalisation
People who develop an arrhythmia after surgery have an increased risk of subsequently being admitted...
Acutus launches expanded suite of left-heart access products
Acutus Medical has announced the commercial launch of an expanded suite of left-heart access pro...
CABG “associated with favourable outcomes and increased long-term survival” among octogenarians
A retrospective study from Kubkin Choi and researchers from Mayo Clinic (Rochester, USA) has found t...
CONFORM pivotal trial of CLAAS system begins enrolment
Conformal Medical has announced the launch of the CONFORM pivotal trial with the enrolment of th...
TVT 2022: DAPT after Watchman FLX LAAO is comparable to currently approved regimens
Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO) using the Watchman...
TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device
Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston Scientific) device ...
TVT 2022: EXPAND registry shows benefit of MitraClip in patients outside of COAPT trial criteria
Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip treatment in secondar...
TVT 2022: New data “debunk idea that patients with pacemakers may not be eligible for TEER”
Data from the first report on patients with a pacemaker lead across the tricuspid valve have sho...
First patient treated in HEAL-IST clinical trial
AtriCure has announced that the first patient has been treated in the HEAL-IST trial, evaluating the...
Patients with mitral annulus calcification at higher risk of mitral valve dysfunction
A retrospective review of more than 24,000 patients who underwent an electrocardiogram (ECG) has fou...
First-in-human results of Captis embolic protection device presented at EuroPCR 2022
Filterlex Medical has announced results from a first-in-human (FIH) study demonstrating the safe...
Meta-analysis reveals “global collateral damage” of pandemic on cardiovascular care
A study has revealed the “global collateral damage” caused by the disruption to cardiac services cau...
UK-wide randomised trial reports non-inferiority of TAVI to SAVR for all-cause mortality at one year
Transcatheter aortic valve implantation (TAVI) was found to be non-inferior to surgery for all-c...
EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies
The use of distal radial artery access for percutaneous coronary intervention (PCI) comes at the...
AATS 2022: Concurrent tricuspid valve surgery and LVAD implantation do not lower the incidence of right heart failure
Concurrent tricuspid valve surgery and left ventricular assist device (LVAD) implantation did n...
SCAI 2022: Analysis looks at coronary IVL outcomes in women and men
New data confirming one-year outcomes with coronary intravascular lithotripsy (IVL, Shockwave Me...
SCAI names Sunil Rao as incoming president
Sunil Rao (Duke University Health System, Durham, USA) has assumed the office of president of th...
Cordella meets safety and efficacy endpoints in SIRONA 2 clinical trial
Endotronix has announced data from the SIRONA 2 clinical trial evaluating safety and efficacy of...
EuroPCR 2022: Sustained reduction in TR seen at one-year in CLASP TR study
One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Edwards Lifesciences) ...
EuroPCR 2022: Single-digit pacemaker rates seen in TAVI with cusp overlap technique
Use of the cusp overlap technique for the deployment of devices in transcatheter aortic valve im...
EuroPCR 2022: First-in-human results of SavvyWire TAVI guidewire support safety
Results of the 20-patient, first-in-human clinical study supporting the safety and efficacy of the S...
EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed
Patients in England with ST-elevation myocardial infarction (STEMI) had an average loss of 1.86 ...
SCAI 2022: PCI for STEMI “yet to reach pre-pandemic levels”
Analysis of data from a US-wide health system suggests that the volume of percutaneous coronary inte...
Biotronik shares new safety data for Magmaris scaffold system at EuroPCR 2022
Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, France) focused on th...
EuroPCR 2022 hears new data on robotic PCI
New data on robotic-assisted percutaneous coronary intervention (PCI) have been presented during a l...
EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity
Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR 2022 (17–20 May, Pa...
EuroPCR 2022: Studies underscore potential of renal denervation as an adjunctive therapy for hypertension
Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France) underscore the pot...
Medtronic gains FDA approval for Onyx Frontier drug-eluting stent
Medtronic has announced that it has received US Food and Drug Administration (FDA) approval for the ...
Cardiovascular News 65 – May 2022: US Edition
In this issue:
New data hint at positive performance of TAVI on structural valve durability
...
Cardiovascular News 65 – May 2022: OUS Edition
In this issue:
New data hint at positive performance of TAVI on structural valve durability
...
Analysis charts “significant” growth of US TEER procedures since 2012
A US analysis comparing trends in transcatheter and surgical mitral valve repair (SMVR) has found a ...
Abbott funds programme to boost diversity in clinical trial leadership
Abbott has announced a new partnership with Women as One to launch a new programme designed to train...
Vijay Kunadian
Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastl...
ADVERTORIAL: Cath lab technologies for medicine in the precision age
This advertorial is sponsored by Siemens Healthineers
In the modern cath lab, having a suite of t...
ADVERTORIAL: TAVI valve durability under the microscope
This advertorial is sponsored by Medtronic
Due to the growth of transcatheter aortic valve im...
Cardiovascular News’ top 10 most popular stories of April 2022
The most read stories from across Cardiovascular News in April 2022 include highlights and late-brea...
DCB in PCI: Adjunctive therapy or standard of care?
This educational supplement, sponsored by Medtronic, explores the science underpinning the use of dr...
“TAVI was my baby, now it is a teenager”
In the history of transcatheter aortic valve implantation (TAVI), 16 April 2002 is a landmark date, ...
Health Canada approval granted for SavvyWire TAVI guidewire
OpSens has announced that it has received Health Canada approval for the SavvyWire, its new guidewir...
Japanese and US regulatory approvals granted for BioFreedom stent
Biosensors International Group has announced both the Japanese Pharmaceuticals and Medical Devic...
First patient enrolled in EXPAND TAVR II trial
Medtronic has announced the first patient enrolment in the EXPAND TAVR II pivotal trial, the fir...
SCAI issues position paper on transaxillary arterial access
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...
Translumina announces launch of dual drug polymer-free coated stent
Translumina has announced the launch of Vivo Isar, its latest generation dual drug polymer-free coat...
“Hybrid” model likely to be a hallmark of the post-pandemic era for heart failure care
The pandemic saw a boom in the use of remote technologies and telehealth for patient monitoring ...
FDA approves coronary use of XO Cross support catheter system
Transit Scientific has announced US Food and Drug Administration (FDA) clearance of its XO Cross...
Quest International and CathWorks partner to scale up FFRangio
Quest International and CathWorks have announced a strategic partnership. Quest has been selecte...
VenusP-Valve gains CE mark
Venus Medtech's transcatheter pulmonic valve replacement (TPVR) system—VenusP-Valve—has received...
CeloNova to seek medical device partnerships
CeloNova BioSciences has announced the strategic decision to focus its core business on creating...
ACC.22: TAVI patients treated with edoxaban see fewer incidences of leaflet thrombosis compared to DAPT
Patients treated with edoxaban for six months after a transcatheter aortic valve implantation (T...
Cardiovascular News’ top 10 most popular stories of March 2022
The most read stories from across Cardiovascular News in March 2022 include a wealth of late-breakin...
FEops Heartguide receives FDA clearance for LAAO planning capabilities
FEops has announced that it received authorisation from the US Food and Drug Administration (FDA...
First patient in Japan treated with Impella 5.5 with SmartAssist
Abiomed has announced that the first patient in Japan has been treated successfully with Impella...
First patient enrolled in BIOMICS study for CTO-PCI
Biosensors International has announced the enrolment of the first patient in the BIOMICS study, a pr...
ACC.22: Analysis finds lower rate of structural valve deterioration with TAVI than SAVR at five years
Patients who received a transcatheter supra-annular self-expanding heart valve had less structural d...
ACC.22: NACMI registry finds reducing rates of death among STEMI patients with COVID-19
Latest results from the North American COVID-19 STEMI (NACMI) registry reported a 25% reduction ...
ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis
A head-to-head comparison of fractional flow reserve (FFR) and intravascular ultrasound (IVUS) guide...
ACC.22: Three-year data show “durable blood pressure reductions” through renal denervation
Long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial have been presented during ...
ACC.22: “Promising” one-year results for Pascal device in CLASP-TR trial
Patients with tricuspid regurgitation (TR) who received a Pascal transcatheter valve (Edwards Lifesc...
Corvia announces publication of REDUCE LAP-HF II data
Corvia Medical has announced publication of analyses from its global, phase III REDUCE LAP-HF II...
ACC.22: FAME 3 shows FFR-guided PCI leads to a faster recovery versus surgery
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) leads to a fast...
SafeCross transseptal balloon gets first commercial use
East End Medical has announced the first commercial use of its SafeCross transseptal radiofreque...
Philips launches Ultrasound Workspace at ACC.22
Royal Philips is launching an echocardiography image analysis and reporting solution—Ultrasound Work...
SCAI aims to minimise risks in medical proctoring of new techniques and technologies
The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...
FDA approval granted for Mitris Resilia mitral valve replacement
Edwards Lifesciences has announced it received approval from the US Food and Drug Administration (FD...
Shockwave coronary IVL gains Japanese approval
Shockwave Medical’s C2 coronary intravascular lithotripsy (IVL) catheter has received regulatory app...
First patient enrolled in PICSO-AMI-V study
Miracor Medical has announced the first patient enrolled in the PICSO-AMI-V study to evaluate Pi...
RADIANCE-II renal denervation trial completes enrolment
Investigators have completed enrolment in the RADIANCE-II pivotal trial of the Paradise ultrasound r...
Carmat sets date for resumption of implants of artificial heart system
Carmat, designer and developer of an advanced total artificial heart, has issued an update on it...
Deep learning tool could predict future myocardial infarction
Researchers have detailed the use of an artificial intelligence-enabled tool for atherosclerotic...
First-in-human study paves way for further clinical trials of Valvosoft
Cardiawave has announced the success of its first-in-human I (FIH I) safety and feasibility clinical...
Expert group sets out principles for device-led hypertension trials
A consensus document outlining design principles and outcome definitions for device-based therapies ...
Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system
Four radial cases using the PH Band System (Medical Ingenuities)—a novel medical device that is ...
Venus Medtech targets European growth with senior appointment
Venus Medtech has appointed Shakeel Osman as senior vice president of sales Europe, responsible for ...
Women less likely to receive cardiogenic shock treatment
Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to r...
Dyspnoea and fatigue “warning signs of greater risk” for NSTEMI patients
Only 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one ye...
Putting “stent regret” behind us
Nick West, chief medical officer and divisional vice president of Global Medical Affairs, Abbott...
Xeltis announces “promising outcomes” in restorative graft trials following EU financing
Xeltis has announced promising initial outcomes from two key vascular trials involving its restorati...
ACC issues clinical guidance on cardiovascular consequences of COVID-19
The American College of Cardiology (ACC) has issued an expert consensus decision pathway for the eva...
CSI’s Propel pVAD system gets first-in-human use
Cardiovascular Systems—CSI—has announced the first in-human experience with Propel, its first-genera...
First patient treated in study of PerQseal+ vessel closure device
Vivasure Medical has announced today that the first patient was treated in a US early feasibilit...
Cardiologists without borders
“When I was one year old, my father died in the war between Israel and Egypt and I was left with...
Ryan Egeland joins Big Sky Biomedical
Big Sky Biomedical has appointed Ryan Egeland as managing director.
“Big Sky Biomedical was f...
Medtronic expands reach of AI-powered surgical video management and analytics platform
Medtronic has announced that it has entered into a contract with Vizient to add Touch Surgery En...
Cardiovascular News’ top 10 most popular stories of February 2022
The most read stories from across Cardiovascular News in February 2022 include training for robotic ...
CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI
Two-year findings from the Low-risk TAVI (LRT) Trial, assessing clinical outcomes after transcat...
CRT 2022: Novel transfemoral mitral valve repair technology wins innovation competition
A novel transcatheter system designed for transfemoral mitral valve repair—the NeoChord Nexus sy...
CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT
Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual antiplatelet therapy...
CRT 2022: Four-year LRT data “support TAVI in low-risk patients”
Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aortic valve implantatio...
VISION study concludes troponin is a benchmark for cardiac surgery risk
Levels of high-sensitivity troponin I after cardiac surgery that were associated with an increased r...
Enrolment in BIOMAG-I trial of resorbable magnesium scaffold completed
Biotronik has announced final enrolment in the BIOMAG-I clinical trial by Michael Haude (Rheinla...
CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX
Results from a new analysis assessing real-world outcomes with the Watchman FLX (Boston Scientif...
Women underrepresented in cardiovascular clinical trial leadership positions
Women remain underrepresented in leading cardiovascular clinical trials, corresponding with unde...
CRT 2022 hears results of animal study of Tria TAVI valve
Results from the first animal study of the Tria transcatheter aortic valve (Foldax) have been pr...
CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years
Final five-year results from the BIOFLOW-V trial, presented during a late-breaking trial session...
Partnership to promote wearable tech in cardiology trials
Wearable technology and digital health specialist Activinsights has announced a partnership agreemen...
High coronary artery calcium score increases risk of heart attack or stroke
Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a mor...
CX 2022 returns to in-person format facing challenges and opportunities in the aortic field
Anticipation is building for the Charing Cross International Symposium 2022 (CX 2022). This will...
Teleflex catheters and coronary guidewires cleared for CTO PCI
Teleflex has announced that the US Food and Drug Administration (FDA) has cleared an expanded indica...
New data underpin drive towards earlier AF ablation strategies
Historically, catheter ablation has been reserved for atrial fibrillation (AF) patients who have...
Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality
Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated with lower in-hospi...
Siemens introduces “integrated” cath lab imaging system, Artis icono biplane
Siemens Healthineers has announced the launch of Artis icono biplane—an angiography system with dete...
Ross procedure “associated with better long-term outcomes” for aortic valve replacement
The “Ross procedure” may be a more favourable option for aortic valve replacement among patients...
Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure
Abbott has announced that the US Food and Drug Administration (FDA) has approved an expanded indicat...
On-pump and off-pump CABG confer similar outcomes over 10 years
A 10-year study monitoring patients receiving “on-pump” or “off-pump” coronary artery bypass graftin...
Heart team approach points to mortality benefit in complex cardiac patients
Consultation by a heart team led to an observed benefit in objective patient outcomes, a prospective...
New technique outperforms manual assessment of thoracic aortic aneurysm growth
Researchers have developed a novel method of measuring growth of thoracic aortic aneurysm, which the...
Robert Califf to return as US FDA commissioner
Cardiologist and researcher Robert Califf has been confirmed as the commissioner of the US Food ...
Expanded robotic training will benefit cardiovascular care
Robotic systems have the potential to fundamentally change the way care is delivered to patients in ...
3D printing to support physician training and coronary device testing
The donation of new 3D printing technology to the Visible Heart Laboratories at the University o...
Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant
Elixir Medical has announced completion of enrolment in the BIOADAPTOR randomised controlled tri...
Boston Scientific closes acquisition of Baylis Medical Company
Boston Scientific has announced the close of its acquisition of Baylis Medical Company, a compan...
MedHub announces investment and pivotal study completion
MedHub has announced the completion of a funding round worth US$1 million in new financing, alongsid...
Supreme drug-eluting stent “safe and effective” in complex coronary lesions
The Supreme healing-targeted drug-eluting stent (Sinomed) is effective and safe at one year acro...
Portsmouth Hospital: How tech is guiding decision-making in the cath lab
Peter Haworth (Portsmouth Hospitals University NHS Trust, Portsmouth, UK) documents how computer-der...
HeartFlow and Longview terminate merger agreement
HeartFlow has announced that it and Longview Acquisition Corporation have mutually agreed to termina...
Lung cancer patients with higher level of coronary calcium at increased risk for adverse cardiovascular events
Lung cancer patients with higher amounts of coronary artery calcium have an increased risk of an adv...
IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation
The use of intravascular ultrasound (IVUS) guidance for implantation of drug-eluting stents in long ...
Cardiovascular News’ top 10 most popular stories of January 2022
The most read stories from across Cardiovascular News in January 2022 include controversy surroundin...
Acarix submits breakthrough designation request to FDA for heart failure diagnosis tool
Acarix has submitted a breakthrough designation request for its technology for heart failure diagnos...
“Game changing” photon-counting CT system arrives at John Radcliffe Hospital
The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundation Trust (OUH, Oxfor...
Philips expands haemodynamic assessment in its Lumify handheld ultrasound system
Royal Philips has announced an update to its handheld ultrasound platform—Lumify—adding Pulse Wave D...
Second phase of ASCENT ASD trial begins
Atheart Medical has announced that it has received US Food and Drug Administration (FDA) approva...
Corvia atrial shunt fails to reduce heart failure events in REDUCE LAP-HF II trial
The placement of an interarterial shunt device—the Corvia atrial shunt (Corvia Medical)—did not ...
First patient enrolled in RISE SC study of coronary balloon
Biosensors has announced the enrolment of the first patient in the RISE SC study, a single arm, pros...
Breakthrough designation granted to CardiaAMP cell therapy system for heart failure treatment
BioCardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Devi...
CroíValve completes funding round for study of Duo system
CroíValve has raised a Series A round to fund a feasibility clinical study with its Duo Coaptati...
SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation
The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the release ...
Abbott’s Nick West points to future role of AI in the cath lab
Abbott has released a second round of insights from its Beyond Intervention global research prog...
ADVERTORIAL: Fresh data paint a positive picture for IVL in both eccentric and nodular coronary calcium
This advertorial is sponsored by Shockwave Medical.
The latest data from the Disrupt CAD clinical...
ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases
This advertorial is sponsored by Medtronic.
Evolut PRO+ is the latest generation of self-expandin...
Susheel Kodali
Born in India and raised in Pittsburgh, USA, Susheel Kodali now practices in New York, where he ...
Cardiovascular News 64 – February 2022: US Edition
In this issue:
Coronary revascularisation guidelines spark debate
New data on IVL in eccent...
Cardiovascular News 64 – February 2022: OUS Edition
In this issue:
Coronary revascularisation guidelines spark debate
New data on IVL in eccent...
STS 2022: Large-scale analysis points toward positive outcomes in bicuspid aortic stenosis patients receiving surgery
Insights from what was described as the “largest and most comprehensive” analysis of isolated su...
PROACT clinical trial results published for On-X mechanical mitral valve
Artivion has announced the publication of PROACT clinical trial results in The Annals of Thoracic Su...
SCAI issues updated expert consensus statement on cardiogenic shock
The Society for Cardiovascular Angiography and Interventions (SCAI) has released its updated exp...
STS 2022: Closer ties between surgeons and cardiologists among goals for incoming president
Cardiothoracic surgeon John H Calhoon from The University of Texas Health Science Center (UT Hea...
STS 2022: Socioeconomic status may impact outcomes after mitral valve surgery
Patients with mitral valve disease who live in disadvantaged communities are more likely to expe...
InnovHeart completes funding round to advance Saturn TMVR system
InnovHeart, developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatme...
JIM 2022 moves to June slot
Organisers of the Joint Interventional Meeting (JIM) have announced that the 2022 edition of the eve...
First patient enrolled in TRANSFORM II study of sirolimus-coated balloon
The first patient has been enrolled in the TRANSFORM II randomised controlled trial assessing th...
“Considerable” reduction in PCI-related radiation reported in last decade
Radiation exposure during percutaneous coronary intervention (PCI) has fallen “considerably” during ...
Burden of aortic stenosis likely to challenge UK treatment capacity, researchers warn
Researchers have warned that the number of people suffering from aortic valve stenosis in the UK cou...
Grant funding for 3D-printed paediatric heart models
Congenita has been named a recipient of the MedTech NAVIGATOR Innovation Grant Scheme, run by NHS me...
Guidelines recognise potential role for earlier endovascular treatment of uncomplicated type B aortic dissection
New clinical practice guidelines have been published today, and are intended to act as “guard rails”...
Scoreflex NC PTCA catheter gains FDA premarket approval
Cardiovascular Systems (CSI) and OrbusNeich Medical Company have announced US Food and Drug Administ...
Gore’s Cardioform Septal Occluder reaches 10-year milestone
WL Gore & Associates has announced that its Cardioform Septal Occluder has achieved 10 years...
Young surgeons to benefit from Transatlantic grant scheme
In a joint programme between the Society of Thoracic Surgeons (STS) and the European Association...
TAVI associated with reduced odds of in-hospital mortality for bicuspid valve patients
A propensity score-matched analysis of the early outcomes of transcatheter aortic valve implantation...
Pioneering pig to human heart transplant heralded as a breakthrough
A 57-year-old patient with terminal heart disease received a successful transplant of a genetically-...
AATS and STS opt not to endorse joint coronary revascularisation guidelines
The American Association for Thoracic Surgery (AATS) and The Society of Thoracic Surgeons (STS) have...
Omicron surge sees STS move 2022 annual meeting online
The Society of Thoracic Surgeons (STS) has moved its 2022 annual meeting from an in-person to a virt...
Terumo welcomes upgraded recommendation for radial access in revascularisation guidelines
Terumo Medical Corporation has welcomed the publication of updated guidelines from the American Coll...
Robocath completes European study of robot-assisted PCI
Robocath has announced the conclusion of its R-Evolution clinical study in Europe, which was aimed a...
Impella gains a trio of regulatory approvals
Regulators in three countries have granted approvals to Impella surgical products. In the USA, the F...
Evolut PRO TAVI valve gains approval in China
Medtronic has announced that the National Medical Products Administration (NMPA) has approved th...
Cardiovascular News’ top 10 most popular stories of December 2021
The most read stories from December 2021 include analysis of the CHEETAH study and the role of mecha...
First patient enrolled in COSIRA-II trial of Neovasc Reducer
Neovasc has announced enrolment of the first patient in the COSIRA-II clinical trial.
COSIRA-II (...
Endotronix announces FDA approval for PROACTIVE-HF pivotal trial design change
Endotronix has announced that the US Food and Drug Administration (FDA) has granted approval for...
Partnership to develop training system for complex valve-in-valve procedures
Biomodex and the Montreal Heart Institute (MHI, Montreal, Canada) are partnering to develop a ne...
FDA clears CavaClear IVC filter removal laser sheath
Royal Philips has announced US Food and Drug Administration (FDA) de novo clearance for the Phil...
First clinical results for Tria biopolymer valve published
Foldax has announced publication of the first clinical results for its Tria biopolymer heart val...
Sapien 3 with Alterra prestent gains FDA approval
Edwards Lifesciences has received approval from the US Food and Drug Administration (FDA) for th...
Research suggests many patients may be safely discharged without opioids after cardiac surgery
Many patients undergoing cardiac surgery may be able to safely and effectively control postoperative...
EMPAKT CHF trial points to change in assessment acute heart failure patients
FAST BioMedical has announced the publication of additional results from the EMPAKT CHF (Estimating ...
Initial implants of Thubrikar TAVI system to commence
Thubrikar Aortic Valve has received approval from a Competent Authority in Poland to conduct initial...
AI improves confidence in CAD detection from a stress echocardiogram
Ultromics has announced the publication of a study assessing its EchoGo platform, powered by Art...
HeartFlow submits premarket application for coronary plaque assessment
HeartFlow has announced it has submitted a 510(k) premarket application to the US Food and Drug Admi...
“Tantalising” data open the door for further study of mechanical aspiration thrombectomy with PCI
Results of the CHEETAH clinical study highlight the potential role of mechanical aspiration thro...
Svelte Medical Systems receives US FDA approval for Slender IDS and Direct RX
Svelte Medical Systems has received US Food and Drug Administration (FDA) approval to commercialise ...
Opsens files 510(k) submission to US FDA for TAVI guidewire
Opsens has filed a 510(k) submission with the US Food & Drug Administration (FDA) for regulatory...
Joanna Chikwe appointed as editor-in-chief of The Annals of Thoracic Surgery
The Society of Thoracic Surgeons (STS) has appointed Joanna Chikwe (chair of the Department of Cardi...
Understanding the risk of acute kidney injury in the cath lab
Huge strides have been made in preventing contrast-associated acute kidney injury among patients...
Heart team approach central to updated coronary revascularisation guidelines
New guidelines for coronary artery revascularisation recommend that treatment decisions should be ba...
Coronary artery modelling technology enables 3D reconstruction of coronary vasculature
RSIP Vision has announced a new coronary artery modelling technology, which enables reconstruction o...
Philips expands cardiac ultrasound portfolio
Royal Philips has announced an expansion of its ultrasound portfolio with new imaging tools and ...
Foldax commences clinical study of Tria surgical aortic valve in India
Foldax has announced that the Drugs Controller General of India (DCGI), India’s regulatory body for ...
Venus Medtech announces Cardiovalve acquisition
Venus Medtech has announced its acquisition of Cardiovalve, a transcatheter mitral and tricuspid val...
SyMap Medical closes US$100 million financing round
SyMap Medical has announced the completion of a financing round which will be used to accelerate...
Restore Medical announces preliminary results from first-in-human use of ContraBand
Restore Medical has announced preliminary results of the first-in-human clinical trial of ContraBand...
Survey: Bullying “commonly experienced” by UK cardiology trainees
One in 10 junior doctors training to be cardiologists in the UK say they have been bullied, the resu...
Interim REVERSE-IT trial results published in NEJM Evidence
Interim results from the REVERSE-IT trial of bentracimab (PhaseBio Pharmaceuticals), which is de...
Cardiovascular News’ top 10 most popular stories of November 2021
Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021, 4–6 N...
AI-based algorithm could predict outcomes after cardiac surgery
A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunction from a single-l...
Soundbite Medical gains fifth US patent for its plaque modification technology
Soundbite Medical Solutions has announced that the US Patent and Trademark Office has issued a paten...
Robocath announces completion of first robotic coronary angioplasty with R-One in China
Robocath has announced the successful completion of what it has described as the first coronary angi...
TMVI is a “reproducible and reliable” tool for eliminating mitral regurgitation
Findings of the CHOICE MI registry show that transcatheter mitral valve implantation (TMVI) is a...
PCR London Valves 2021: ENVISAGE TAVI AF and the future of TAVI trials
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, presented...
Mirvat Alasnag
Mirvat Alasnag is the Gulf region’s first female interventional cardiologist. Currently the director...
CSI recalls Wirion embolic protection device
Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic protection systems ...
PCR London Valves: Two-year GALILEO data show comparable outcomes for TAVI with self-expanding or balloon-expandable valves according to physician discretion
Two-year findings of a post-hoc study from the GALILEO trial, investigating the clinical outcome...
PCR London Valves: First clinical data backs use of Jenavalve TAVI system in patients with aortic regurgitation
First clinical results of transcatheter aortic valve implantation (TAVI) using the Jenavalve sys...
PCR London Valves hears first results from NeoChord Nexus mitral repair device
The first 30-day results following the implantation of the NeoChord NeXuS transcatheter system f...
First 20 patients treated in first-in-man study of SavvyWire TAVI guidewire
Opsens has announced the successful treatment of 20 patients leading to the completion of the first ...
First patients enrolled in FAST III study of vFFR-guided PCI
The first patients have been enrolled in the FAST III trial at the Erasmus University Medical Center...
ESC publishes pandemic guidance on diagnosis and management of cardiovascular disease
European Society of Cardiology (ESC) guidance for the diagnosis and management of cardiovascular dis...
SCAI pushes revised standardised language to improve cardiogenic shock care
New guidance on the diagnosis and presentation of cardiogenic shock aims to simplify and standar...
Findings of meta-analysis “move the conversation forward” on left main revascularisation
A meta-analysis comparing percutaneous coronary intervention (PCI) using a drug-eluting stent (D...
AHA 2021: Updated risk score aims to predict contrast-associated kidney injury after PCI
An updated risk score to predict possible contrast-associated acute kidney injury (CA-AKI) among...
AHA 2021: VEST device may lead to increased saphenous vein graft longevity after CABG
Use of a novel, venous external support device (VEST, Vascular Graft Solutions) may lead to incr...
HeartVista receives FDA clearance for use of its AI software on Siemens MRI scanners
HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance to deliver its AI-ass...
AHA 2021: RAPID CABG trial finds in favour of bypass surgery sooner after ticagrelor cessation
Coronary artery bypass graft sugery (CABG) between two and three days after ticagrelor cessation was...
AHA 2021: Asymptomatic AS patients benefit from early valve replacement surgery
Asymptomatic patients with severe aortic stenosis (AS) may benefit from early aortic valve replaceme...
What to expect from AHA 2021
Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2021, 13–15 November,...
ADVERTORIAL Chronic total occlusion: The last frontier in the cath lab
This advertorial is sponsored by iVascular
Treatment of a chronic total occlusion (CTO)—a complet...
“Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021
Early data presented at the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021; ...
Abbott research highlights opportunities for improvements in diagnosis and treatment of cardiovascular disease
Abbott has released new research from its Beyond Intervention initiative, a multi-year global resear...
Ron Waksman joins SIS Medical AG advisory board
SIS Medical AG has appointed Ron Waksman, associate director Division of Cardiology, MedStar Was...
Lessons from SURTAVI
Transcatheter aortic valve implantation (TAVI) pioneer and principal investigator of the SURTAVI tri...
Cardiovascular Systems announces enrolment in first-in-human study of everolimus-coated coronary DCB
Cardiovascular Systems has announced the start of enrolment in a first in-human trial of the coronar...
Patients more likely to survive a cardiac arrest in the operating room than the cath lab
Patients who went into cardiac arrest in the cardiac cath lab were more likely to survive to hospita...
Two-year results of mitral valve repair using ChordArt device published
CoreMedic has announced the publication of two-year follow-up results from the first in-human CHAGAL...
Medtronic announces 2045 net zero emissions ambition to combat climate change
Medtronic has announced its ambition to achieve net zero carbon emissions by fiscal year 2045 across...
TCT 2021: BIOSOLVE-IV data offer reassurance over rates of scaffold thrombosis from Magmaris bioresorbable scaffold
Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascular Therapeutics annu...
TCT 2021: Six-month TRISCEND results “encouraging” for Evoque tricuspid valve
Six-month results from the TRISCEND study of the Evoque (Edwards Lifesciences) transcatheter tri...
TCT 2021: Early data presented for Intrepid TMVR using transfemoral delivery system
Early data for the self-expanding Intrepid (Medtronic) transcatheter mitral valve replacement (T...
TCT 2021: SWISS-APERO trial finds lower rate of peri-device leak in Amulet compared to Watchman FLX LAAC device
Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovascular Therapeutics an...
TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens
Patients receiving antiplatelet therapy following percutaneous coronary intervention (PCI) devel...
TCT 2021: Studies show improved outcomes for high-risk PCI patients using Impella
The final results of the PROTECT III and Restore EF prospective studies demonstrate improved out...
TCT 2021: LAAC remains non-inferior to NOAC for cardiovascular events at long-term follow-up
Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K-antagonists (NOACs)...
TCT 2021: Five-year SURTAVI data show comparable performance for TAVI and SAVR on mortality, stroke
Five-year clinical and echocardiographic outcome data from the SURTAVI randomised trial comparin...
TCT 2021: CHOICE-CLOSURE finds higher rate of access-related vascular complications in plug-based closure strategy post-TAVI
Results from the largest randomised trial to date comparing different closure device strategies ...
TCT 2021: TAVI in low-risk patients is cost effective, PARTNER 3 finds
An economic analysis of data from the PARTNER 3 randomised trial, comparing transcatheter aortic...
TCT 2021: CHEETAH study demonstrates safety of continuous aspiration to remove blood clots in the heart
Penumbra has announced that the CHEETAH clinical study of its Indigo system CAT RX catheter succ...
TCT 2021: “Sustained benefit” in patients undergoing IVL prior to coronary stenting
One-year outcomes from the Disrupt CAD III clinical study of Shockwave intravascular lithotripsy (IV...
TCT 2021: Patients with diabetes undergoing PCI have less target lesion failure with amphilimus-eluting stents
Results from SUGAR, a randomised controlled, multicentre trial conducted exclusively in patients wit...
TCT 2021: Randomised trials show “consistent” reduction in blood pressure through renal denervation
Randomised placebo-controlled trials show consistently that renal denervation provides significant r...
TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation
Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing endovascular ultrasoun...
TCT 2021: QFR-guided lesion selection improves PCI outcomes in FAVOR III trial
Lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed phys...
TCT 2021: CABG “remains the treatment of choice” for complex, three-vessel coronary artery disease
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) did not meet no...
Cardiovascular News 63 – November 2021: US Edition
In this issue:
MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT)
...
Cardiovascular News 63 – November 2021: OUS Edition
In this issue:
MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT)
...
TCT 2021: Philips to showcase developments in its interventional portfolio
Royal Philips has previewed updates in its product portfolio and new data due to be shared at the Tr...
Procyrion’s Aortix percutaneous mechanical circulatory support device features at TCT 2021
Procyrion has announced the presentation of studies at the Transcatheter Cardiovascular Therapeutics...
Aktiia announces Series A funding round
Hypertension health-tech firm Aktiia has announced a US$17.5 million Series A round of funding t...
ReValve Solutions announces first use of its Palmetto mitral valve replacement system
ReValve Solutions has announced that it has successfully completed the first-in-human use of its tra...
TCT 2021: Studies to highlight patient outcomes with Impella
Results from two studies of the Impella heart pump device will be presented at the Transcatheter Car...
Bifurcation lesions: Exploring the latest science
This educational supplement, sponsored by Medtronic, explores the latest evidence covering the treat...
AHA and ACC release clinical guidelines for evaluation of chest pain
Joint clinical practice guidelines have been issued by the American Heart Association (AHA) and the ...
EACTS speakers question evidence underpinning guidelines for left main revascularisation
Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 Octobe...
Longest available real-world follow-up data for Tendyne valve support use of device in select patients
The longest available real-world follow-up data of transcatheter mitral valve implantation (...
Enrolment completed in study of Teleflex QuikClot device
Teleflex announced the completion of patient enrolment in a clinical study evaluating the performanc...
Research finds poor level of surveillance following aortic dissection repair
Patients who survive an aortic dissection often fail to receive comprehensive post-surgical fo...
CRF waives cost for digital access to TCT 2021
The Cardiovascular Research Foundation (CRF) has announced that the digital component of the Transca...
PIONEER III trial results demonstrate safety and efficacy of HT Supreme stent
Sinomed has announced that the PIONEER III clinical trial results for its HT Supreme drug-elutin...
Cardiac CTA parameters predict post-TAVI mortality
Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) improves predictive pe...
First European implants of Trilogy TAVI system completed
JenaValve Technology has announced the first commercial implants with the Trilogy heart valve System...
Heartflow announces start of REVEALPLAQUE clinical trial
HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate the company’s non-inv...
Study charts “inequities” in growth of TAVI in US hospitals
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has predominantly centred...
Ethnic and racial minority cardiologists face professional discrimination and exclusion
Ethnic and racial minority cardiologists report career satisfaction but face professional discrimina...
EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials
The underrepresentation of women in clinical coronary revascularisation trials may encourage tre...
Clinical study of SavvyWire TAVI guidewire commences
OpSens has announced the commencement of the human clinical study utilising the SavvyWire, and succe...
Next generation of aortic surgeons need open and endovascular skills
Building and maintaining expertise in both open and endovascular surgical techniques will play a...
ReCor Medical’s Paradise ultrasound renal denervation system used in first German cases
ReCor Medical has announced that its Paradise ultrasound renal denervation system is now available f...
Baylis Medical Company to sell its cardiology business to Boston Scientific
Baylis Medical Company has reached an agreement to sell its cardiology business to Boston Scientific...
Philips’ Bert van Meurs discusses the future of imaging in the cath lab
Bert van Meurs is the chief business leader for Image Guided Therapy within Royal Philips, the multi...
NeoChord announces completion of first-in-human case with NeXus TMVr technology
NeoChord has announced successful completion of the first-in-human procedure with the NeoChord NeXuS...
Cardiovascular News’ top 10 most popular stories of September 2021
Top stories for September included more highlights from the European Society of Cardiology’s 2021 co...
Lankenau Heart Institute and Philips announced integrated cardiovascular solutions partnership
Royal Philips and Lankenau Heart Institute part of Main Line Health (Wynnewood, USA) have announced ...
FDA monitoring gender differences in outcomes with LAAO devices
The US Food and Drug Administration (FDA) has informed healthcare providers of recent information ab...
Enrolment completed in study of Tria aortic valve
Foldax has announced completion of enrolment in the US early feasibility study of the Tria surgical ...
Siemens launches Luminos Impulse fluoroscopy system
Siemens Healthineers has launched the Luminos Impulse fluoroscopy system, including features such as...
Abbott’s Amplatzer Talisman gains FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's Ampla...
Biotronik gains FDA approval for the Orsiro Mission drug-eluting stent
Biotronik has announced that it has received US Food and Drug Administration (FDA) approval of i...
Waiting list mortality for coronary procedures exacerbated during pandemic
Patients awaiting coronary artery bypass grafting (CABG) or percutaneous coronary intervention (...
Open Stent Solution closes €2.5 funding round
Open Stent Solution (OSS) has announced the closing of a €2.5 million Seed financing round. The fund...
HRX digital health event moved to September 2022
The Heart Rhythm Society (HRS) has announced that its cardiovascular digital health conference—HRX—h...
Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna
Capturing the latest developments in the comprehensive treatment of aortic disease—from the aortic v...
ADVERTORIAL: Optimising TAVI device choice
This advertorial is sponsored by Medtronic
As transcatheter aortic valve implantation (TAVI) ...
Neovasc to begin COSIRA-II trial of Reducer for refractory angina
Neovasc has announced that it has received Food and Drug Administration (FDA) approval for the inves...
FDA approves Abbott’s Epic Plus tissue valves for mitral and aortic valve replacement
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company’s Epic ...
Registry data show comparable outcomes for bicuspid and tricuspid TAVI in low-risk patients
Patients at low surgical risk who had undergone transcatheter aortic valve implantation (TAVI) f...
Surgical team completes first implant of Aeson bioprosthetic heart in a female patient
A cardiothoracic surgical team with UofL Health–Jewish Hospital and the University of Louisville...
Ultrasound guidance “should be routine” for transfemoral TAVI access
Ultrasound-guided transfemoral transcatheter aortic valve implantation (TAVI) is associated with...
Randomised trials needed to evaluate safety and efficacy of TMVR
Randomised trials are needed to evaluate the safety and effectiveness of transcatheter mitral va...
Abbott receives FDA approval for Portico with FlexNav TAVI system
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's P...
OpSens receives Health Canada approval to begin clinical study of TAVI guidewire
OpSens has announced that it has received Health Canada approval to commence the first in-man study ...
Renal denervation: The most advanced and efficacious interventional approach to treat hypertension
Following the release of the European Society of Hypertension’s (ESH’s) updated position paper o...
Long-term preclinical results of Xeltis’ restorative CABG graft presented at ISACB 2021
One-year data from preclinical trials of Xeltis restorative coronary artery bypass graft (XABG) show...
TCT 2021: Late-breaking trials programme announced
The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking trial and science pr...
ESH position paper highlights renal denervation as a third option for hypertension management
European Society of Hypertension (ESH), the leading hypertension (HTN) society in Europe, presented ...
Peijia Medical announces first implant in the clinical trial of its TaurusNXT TAVI system
Peijia Medical has announced the initiation of its multicentre clinical trial for TaurusNXT, the...
Christoph Naber
Christoph Naber (Essen, Germany) talks to Cardiovascular News about his career in interventional car...
New imaging technique has the potential to identify patients at high risk of aortic degeneration
Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potential to identify patien...
CytoSorbents files IDE for clinical trial of DrugSorb-ATR used during cardiothoracic surgery
CytoSorbents has filed an investigational device exemption (IDE) application to gain US Food and Dru...
STENTiT makes trio of appointment to its medical advisory board
STENTiT, a medical device company bringing a novel class of regenerative endovascular implants f...
No-touch CABG technique “reduces risk of vein graft occlusion” after 12 months
When a modified surgical technique was used to gently remove sections of leg veins used in coronary ...
ABILITY Diabetes Global enrols thousandth patient
Concept Medical has announced the enrolment of the thousandth patient in ABILITY Diabetes Global (Ra...
Digital app speeds up time to STEMI care
“During a heart attack time is myocardium,” says Annapoorna Kini (New York, USA) discussing the ...
Cannabis use in younger adults linked to increased risk of myocardial infarction
Adults younger than 45 years who reported recently using cannabis were two times more likely to have...
Cardiovascular News’ top 10 most popular stories of August 2021
August’s top 10 features a stark warning over representation of women in clinical trials relating to...
HeartFlow announces enrolment of first three patients in FUSION trial
HeartFlow has announced that physicians at Erasmus MC Hospital (Rotterdam, The Netherlands) have...
ESC 2021: STOPDAPT-2 ACS does not support clopidogrel monotherapy one-month after ACS
Findings of the STOPDAPT-2 ACS trial presented during a hot line session at the European Society...
ESC 2021: Abbott’s Amulet occluder shows promise against Watchman device in AF treatment
Abbott has announced late-breaking data from the Amulet LAA Occluder IDE trial, a multicentre, h...
ESC 2021: Drones touted as the future of defibrillator delivery
The world’s first feasibility study has found that drones can be used to deliver defibrillators to p...
ESC 2021: New guidelines for the diagnosis and treatment of acute heart failure published
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chr...
ESC 2021: Study charts impact of following health advice after a heart attack
Adherence to lifestyle advice and medications could add seven healthy years of life after a heart at...
Second hospital implants Aeson bioprosthetic artificial heart
CARMAT has announced the second centre implanting its bioprosthetic artificial heart, Aeson, in the ...
Medtronic gains FDA approval for its latest-generation TAVI system
Medtronic has announced US Food and Drug Administration (FDA) approval of its newest-generation, sel...
ESC 2021: Family history outweighed by lifestyle choices in study of premature heart attacks
Young heart attack victims are more likely to be smokers, obese, and have high blood pressure or...
EMPOWER trial to study Carillon mitral contour system
Cardiac Dimensions has announced the launch of the US pivotal study the EMPOWER trial, evaluatin...
Urgent TAVI patients more likely to be readmitted than elective cases
Readmissions within 30 days are more common following urgent, rather than elective, transcathete...
Cardiovascular News 62 – August 2021: OUS Edition
In this issue:
Meta analysis draws out debate on coronary revascularisation
What to expect w...
Cardiovascular News 62 – August 2021: US Edition
In this issue:
Meta analysis draws out debate on coronary revascularisation
What to expect w...
Ten-year outcomes of Yukon DES in diabetic patients published in JAHA
Translumina has announced the publication of 10-year clinical outcome data for its Yukon drug-elutin...
Ultromics completes US$33 million Series B funding round
Ultromics, a developer of AI enabled cardiovascular imaging solutions, has announced that it has rai...
FDA grants breakthrough device designation to Impella ECP
The US Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed...
Algorithm predicts heart failure hospitalisations
Biotronik has announced the results from a new study published in EP Europace this week confirming t...
Sinomed announces the first commercial implantation and European launch of the HT Supreme DES
Sinomed has announced the first commercial implantation of the HT Supreme drug-eluting stent (DE...
App launched to cut time to treatment for STEMI patients
Physicians at Mount Sinai Health System (New York, USA) have developed a mobile application to exped...
Second US FDA breakthrough device designation granted to CytoSorbents’ DrugSorb-ATR
CytoSorbents has been granted a second breakthrough device designation for its DrugSorb-ATR antithro...
Abbott’s Amplatzer Amulet gains US FDA approval
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's ...
Occlutech gains IDE approval for OCCLUFLEX pivotal study
Occlutech Holding has announced the conditional US Food and Drug Administration (FDA) approval of it...
“Virtual contrast agent” could offer benefit in cardiac MRI assessment
An imaging technology developed using artificial intelligence (AI) could become an alternative for l...
Caption Health gains NTAP authorisation from CMS for AI-guided ultrasound platform
Caption Health has announced that the Centers for Medicare and Medicaid Services (CMS) have appr...
Women underrepresented in cardiovascular clinical trials
Women remain underrepresented in cardiovascular clinical trials despite initiatives to ensure broade...
Realview Imaging gains FDA approval for Holoscope-i system
RealView Imaging has announced that it has received US Food and Drug Administration (FDA) 510(k) cle...
Back in the room: A welcome return to in-person education
With the COVID-19 pandemic having switched virtually all of the major meeting in the cardiovascu...
Cardiovascular News’ top 10 most popular stories of July 2021
Our top 10 stories of July 2021, including: A milestone for coronary balloon angioplasty; highlights...
Analysis reports “dramatic” drop in cardiac surgery procedures during COVID-19
The largest analysis of its kind to look at the impact of COVID-19 on adult cardiac surgery volu...
US launch for Abbott’s Ultreon AI-based coronary imaging platform
Abbott has announced that it has received US Food and Drug Administration (FDA) clearance for its la...
Edwards’ Konect Resilia and Mitris Resilia gain Health Canada approval
Edwards Lifesciences has announced that it has received regulatory approval from Health Canada for b...
PCI procedures drop by 10% in USA since 2010, research suggests
The USA saw a 10% decline in percutaneous coronary intervention (PCI) procedures between 2010 an...
AngelMed launches its Guardian device in the USA
Angel Medical Systems (AngelMed) has announced the first commercial implantation and US launch of it...
TVT 2021: MitraClip reduces hospitalisation in patients with secondary MR and heart failure
An analysis of the rates rehospitalisation and mortality in heart failure patients with secondar...
Medtronic launches Prevail DCB in Europe
Medtronic has announced the launch of the Prevail drug coated balloon (DCB) catheter in Europe follo...
ADVERTORIAL: DCB pioneer welcomes deliverability after first case with Medtronic’s brand new Prevail™ coronary DCB
This advertorial is sponsored by Medtronic
The first case using the Prevail (Medtronic) pacli...
CathWorks FFRangio system receives reimbursement approval in Japan
CathWorks has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has appr...
TVT 2021: Aborted TEER leads to poorer outcomes in mitral valve surgery
Among patients undergoing mitral valve surgery after failed transcatheter edge-to-edge mitral va...
TVT 2021: 3M study suggests minimalist TAVI is safe, leads to “substantial” cost savings
Clinical and economic results from the 3M TAVR economic study have been presented at TVT 2021 (T...
TVT 2021: Outcomes in low-risk bicuspid and tricuspid TAVI patients similar at one year
Patients with bicuspid aortic stenosis may benefit as much from transcatheter aortic valve impla...
TVT 2021: Two-year PINNACLE FLX results report low rate of ischaemic stroke for Watchman FLX
Two-year results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-...
MedAlliance launches Origin balloons for vessel preparation
MedAlliance has launched Origin SC and Origin NC, two high performance balloons for vessel preparati...
Ancora Heart secures US$80 million in financing
Ancora Heart has closed US$80 million in equity financing, with the funds to be used to accelera...
HeartFlow announces merger agreement
HeartFlow has entered into a definitive business combination agreement with Longview Acquisition...
First Aeson bioprosthetic artificial heart implanted in USA
Carmat has announced the first implantation of its bioprosthetic artificial heart, Aeson, in the USA...
Pacemaker implantation after SAVR points to increased mortality and heart failure hospitalisation
Patients undergoing permanent pacemaker implantation after surgical aortic valve replacement (SA...
First patients treated with reSept ASD occluder in IDE trial
atHeart Medical has announced the successful treatment of the first five patients in its ASCENT ...
FDA approval for SafeCross transseptal RF system
East End Medical has announced it has received US Food and Drug Administration (FDA) clearance f...
Cardiovascular societies demand action to combat physician burnout
Global action is needed to improve clinician wellbeing, according to four leading cardiovascular hea...
Xeltis initiates synthetic restorative pulmonary heart valve pivotal trial
Xeltis has announced that it has started a pivotal trial for a synthetic restorative pulmonary valve...
Common cath lab practices under the microscope in AHA review
The American Heart Association (AHA) has published a scientific statement challenging “tradition...
Cardiovascular News’ top 10 most popular stories of June 2021
Our top 10 stories of June 2021, including: Analysis of the data for transcatheter aortic valve impl...
CytoSorbents gains IDE for STAR-T trial to remove ticagrelor during cardiothoracic surgery
CytoSorbents has received approval for its investigational device exemption (IDE) application to con...
Carta Healthcare’s AI software certified for use in CathPCI Registry
Carta Healthcare has announced that it has been certified as a National Cardiovascular Data Registry...
Sinomed partners with NUI Galway for HT Supreme stent trial
Sinomed has announced a partnership with the National University of Ireland Galway (NUI Galway, ...
More experienced TAVI centres “less likely to use heart team approach”
Assessment of patients by both interventional cardiologists and cardiac surgeons prior to transc...